TXA Prophylaxis No Help for Bleeding in Blood Cancers

(MedPage Today) -- Prophylactic antifibrinolytic therapy with tranexamic acid (TXA) failed to reduce bleeding during treatment for hematologic malignancies, a first-of-its-kind randomized trial showed.
The incidence of grade 2+ bleeding decreased...